Clal Biotechnology reported -5155000 in Interest Income for its fiscal quarter ending in December of 2022.


Interest Income Change Date
Compugen 1.07M 1.39M Jun/2025
Life Technologies 10.93K 10.93K Jun/2025
RedHill Biopharma 7.1M 14.49M Jun/2023